• WCG’s eCOA portfolio and imaging analysis technology from NeuroRx are now part of Clario!

menu-close-icon
Your using an unsupported browser. Please update to a modern browser for a better experience.
Skip to content
Clario Clario
  • Solutions
    • Study Endpoints
        • Cardiac safety and efficacy endpoint solutions for all phases, anywhere in the world.

        • Collect continuous ECG data in site-based or hybrid trials with our flexible solutions and patient-friendly devices.

        • Collect and centrally analyze accurate, consistent, quality blood pressure data from site-based to hybrid trials.

        • Monitor every heartbeat with precision to assess safety and efficacy throughout your site-based or hybrid clinical trial.

        • Fulfill your ICH E14 requirement early, minimize risk and potentially reduce costs throughout your trial.

        • Leverage our key opinion leaders to understand the complex regulatory landscape while minimizing risk with confidence.

        • Make your clinical trials easier, faster, more engaging and accessible to all.

        • Enjoy flexible, fast and confidential site assessments at home.

        • Enhance your ePRO data with photo and audio capture.

        • Accelerate your clinical trial setup with Clario’s pre-validated and configured eCOA assessments.

        • Improve data accuracy and reduce variability in scoring with Clario’s training solutions.

        • Your trusted partner for the richest eCOA endpoint data in your clinical trial.

        • Monitor Suicide Ideation and Behavior (SIB) in clinical trials effectively with Clario’s suicide assessment tool, eC-SSRS.

        • Accelerate drug development and reduce risk with Clario’s comprehensive medical imaging core lab services.

        • The Clario team includes medical imaging experts and globally recognized key opinion leaders (KOLs) representing multiple disciplines.

        • Clario’s Image Redact AI automatically redacts sensitive patient identifiers from videos, photos and PDFs.

        • Secure accurate results, streamline your processes, and meet your unique needs with our imaging platform.

        • Leverage our full range of medical imaging and diagnostic imaging modalities, including CT Scans, Endoscopy, MRIs, and more.

        • Securely collect, store, and share de-identified images for compliance with 21 CFR Part 11 and EU GDPR standards.

        • Clario's complete solution for measuring objective digital endpoints of mobility with wearable sensor technology.

        • The Opal V2R® is a research grade wearable sensor that delivers meaningful outcomes and richer insights.

        • Explore more than 750 scientific publications that reflect the technical and clinical applications of Clario’s Opal® System.

        • Everything you need for high quality, low variability pulmonary function data and high patient compliance for clinical trials.

        • Centralized, on-site pulmonary function testing for clinical trials.

        • Remote spirometry testing for respiratory clinical trials.

        • Assess cough frequency, cough severity and other lung sounds such as crackles or rhonchi for clinical trials.

        • Assess the capacity of the lungs for effective gas transfer.

        • Advanced, cloud-native technologies and clinical trial software to screen, clean, QC and assess complicated data.

        • Collect, centralize and manage participant screening and eligibility data with customized workflows.

        • Boost stakeholder insights with business intelligence (BI) tools, analytics for endpoint and safety risks, and data exchange solutions.

        • Securely collect, store and share compliant images in the cloud to keep clinical trial sponsors and labs informed.

    • Segments
    • Study Phases
    • Technology
  • Therapeutic Areas
    • Cardiovascular & Metabolic Icon RGBCardiovascular & Metabolic
    • Dermatology Icon RGBDermatology
    • Type 2 Diabetes and Obesity iconDiabetes and Obesity
    • Gastroenterology Icon RGBGastroenterology
    • Hepatology Icon RGBHepatology
    • Infectious Disease Icon RGBInfectious Diseases
    • Muskoskeletal Icon RGBMusculoskeletal
    • Neuroscience Icon RGBNeuroscience
      • Neuroscience Indications
    • Oncology Icon RGBOncology
    • Ophthalmology Icon RGBOphthalmology
    • Respiratory Solutions IconRespiratory
  • Resources
    • Blog Articles
    • Case Studies
    • Downloads
    • Events
    • External Publications
    • Webinars
  • About
    • The Clario Story
    • Careers
    • Corporate & Social Responsibility
    • Information Security
    • Leadership
    • Legal & Privacy
    • Newsroom
    • Scientific Expertise
    • Strategic Partnerships
    • Values & Culture
  • Support
    • Customer Support
    • In-Country Cardiac Safety Support
  • Solutions
    • Study Endpoints
      • Cardiac Solutions
        • Cardiac Solutions
        • Arrhythmia Analysis
        • Blood Pressure Services
        • ECG — On-site to DCT and Phase I-IV
        • Phase I/TQT Cardiac Assessment
        • Regulatory Consultation and Statistical Analysis Expertise
      • Clinical Adjudication
      • eCOA
        • eCOA Clinical Trials
        • eCOA Live
        • eCOA Multimedia
        • eCOA Rapid Start
        • eCOA Rater and Participant Training
        • eCOA Rescue Studies
        • Suicidal Ideation
      • Medical Imaging
        • Medical Imaging
        • Image Redact AI
        • Imaging Platform
        • Medical Imaging Science Team
        • Modalities
        • SMART Submit
      • Precision Motion
        • Precision Motion for Clinical Trials
        • Precision Motion for Research
        • Precision Motion: Scientific Publications
      • Respiratory Solutions
        • Respiratory Solutions
        • Site-Based Spirometry
        • Virtual Home Spirometry
        • Cough and Lung Sounds
        • Diffusing Capacity (DLCO)
      • Trial Enablement
        • Trial Enablement
        • Eligibility Solution
        • Reporting & Analytics
        • Source Document Manager
    • Segments
      • Biotechs
      • CROs
      • Pharma
    • Study Phases
      • Phase I
      • Phase II/III
    • Technology
      • Artificial Intelligence (AI)
      • Hybrid Trials
  • Therapeutic Areas
    • Cardiovascular & Metabolic
    • Dermatology
    • Diabetes and Obesity
    • Gastroenterology
    • Hepatology
    • Infectious Diseases
    • Musculoskeletal
    • Neuroscience
      • Headache Disorders
      • Movement Disorders
      • Multiple Sclerosis
      • Pain Disorders
      • Psychiatric Disorders
    • Oncology
    • Ophthalmology
    • Respiratory
  • Resources
    • Blog Articles
    • Case Studies
    • Downloads
    • Events
    • External Publications
    • Webinars
  • About
    • The Clario Story
    • Corporate & Social Responsibility
    • Information Security
    • Leadership
    • Legal & Privacy
    • Scientific Expertise
    • Strategic Partnerships
    • Values & Culture
  • Support
    • Customer Support
    • In-Country Cardiac Safety Support
  • Careers
    • Life at Clario
  • Newsroom
  • Login
  • Contact sales
    • Log in
    • Contact sales
  1. Home Resources Blog Articles Benefits of Oncology Image Collection Reconciliation

Benefits of Oncology Image Collection Reconciliation

Proactive reconciliation of oncology imaging data is crucial for successfully expediting drug development

Michael O’Neal, M.D. – Chief Medical Officer, Imaging at Clario

The quality of medical imaging in oncology clinical trials can make or break the success of your new therapy. Imaging is performed on an ongoing basis while patients receive therapy to evaluate their response to treatment and is the primary endpoint to evaluate drug efficacy in clinical trials. If medical images are missing, or scans are not of consistently high quality, you risk overlooking critical insights which can affect your oncology drug’s approval progress. Now more than ever, biotechnology companies are trying to leverage an expedited regulatory pathway when possible, making data consistent, reconciled, and clean is important to the efficiency and success of the study. Since this data is so crucial to oncology trials, shouldn’t we ensure that the image collection data is correct on an ongoing basis rather than only a few times during a study? 

Image scan collection in particular is a very important component of oncology trials, and reconciling this information proactively can prove to be very valuable. Ensuring this information is consistent and accurate between the sponsor and the imaging vendor is crucial. 

The reconciliation processes

During the course of a study, image scan collection information is usually captured in the sponsor’s Interactive Voice Response (IVRS) or EDC system. Image scan collection information is stored at the imaging vendor using the designated image repository software. Sponsors also provide an enrollment report or a scan listing to ensure that the vendor is up to date with the information of all subjects that are participating in a trial.

This data collected at the vendor is solely based on the protocol-required imaging scans that are being submitted from the site. Looking at an IVRS or EDC system may not tell you if the images were received at the imaging vendor. At times, the vendor does not have all the scans the Sponsor needs. This can be due to many reasons:

  • Scans were never performed and thus were never sent to the vendor
  • The Sponsor doesn’t have this info in their IVRS or EDC
  • The scans are still pending submission from the Site
  • The vendor has queried the Site and they have not yet responded

Therefore, to ensure all necessary scans are captured, it is essential that on a routine basis (preferably monthly), the imaging scans are proactively reconciled with the sponsor’s electronic system against the imaging vendor’s image repository system. Periodically reviewing this data can be more efficient and help reduce errors. It can also better allow the sponsor to promptly identify gaps and follow up with sites that are not submitting scans for the vendor to review.

Best practices for image reconciliation

By implementing an effective “missing” versus “expected” reconciliation plan, you’ll allow for a more seamless review of the imaging scans. You can also eliminate any unnecessary work for sites, CRO, and EDC vendors. This process ensures that imaging data is intact, and no further follow-up is required, resulting in clean and complete imaging data set. By performing this reconciliation activity, vendors are better able to proactively identify any missing, discrepant, or unscheduled imaging scans that need site follow-up in a timely manner. Not performing this activity on a routine basis can affect essential deliverables such as interim analysis, ad-hoc transfers, and database locks. To make the reconciliation activity a seamless one, there are a number of tools and technologies that can be used to improve the accuracy and efficiency of image reconciliation. These tools include:

  • Image-matching algorithms: These algorithms can be used to identify and match images of the same patient.
  • Image-storage and management systems: These systems can be used to store and manage large volumes of oncology images.
  • Workflow management systems: These systems can be used to automate the process of oncology image reconciliation.

The addition of these tools and technologies can help to improve the accuracy and efficiency of oncology image reconciliation to ultimately lead to better outcomes for patients impacted with cancer.

Learn more

Our team of experts are ready for your questions about your next oncology clinical trial. To contact us, email [email protected].

From electronic image transfer to independent analysis, Clario offers a fully integrated, end-to-end solution. Our clinical imaging solution is data-privacy compliant and enables easy electronic image submission, all with a fully integrated, efficient, and streamlined process. Fusing our deep scientific expertise and global scale into the broadest endpoint technology platform, we empower our partners to improve patient care.

Learn more about how Clario’s Medical Imaging expedites oncology drug development

Download datasheet
Back to articles
Share
Twitter Facebook LinkedIn

Latest articles

See all articles
Article

Researcher spotlight: Dr. Lauren Tueth

Precision Motion

Read
Article

Researcher spotlight: Brice Cleland

Precision Motion

Read
Article

Researcher spotlight: Josefa Domingos

Precision Motion

Read
Clario logo
    • Solutions
    • Therapeutic Areas
    • About
    • Resources
    • Careers
    • Newsroom
  • Get in touch

    • Contact
    • Support
    • Customer portal

Follow us

Twitter LinkedIn Glassdoor
×

Contact sales

If you are looking for a partner to help you generate the richest clinical evidence with the right clinical trial technology, please fill in the form below.


Not what you're looking for?

Please visit our Contact Page for customer support, office locations, or media contacts.

  • © 2025 Clario

    • Legal and Privacy Terms
    • Information Security
    • Cookie Policy
    • Impressum